Abstract:Objective: To study the Space-time Change of Vasculogenic Mimicry in the melanoma transplant tumour.Methods:The mouse melanoma transplant tumor model was made by Subcutaneous injecting in the C57mouse with B16 melanoma cell susspension liquid.When tumor appears,we choose one mouse each day randomly according to random number chart and kill it.Normal HE stain,immunohistochemistry stain and PAS stain were used.Then count the Vasculogenic mimicry and endothelial vessel under high-power microcope in centre and outside area.SPSS 10.0 statistic software was used when P<0.05 was significant.Results: There are PAS-positive patterned vessels in the tumor tissue at the early phase of melanoma and erythrocytes inside the vessel.The structure decreases gradually in the center and outside area and the density of the two area has no significant difference.The endothelial vessels decrease gradually in center and outside area as well.There is negative correlation between the vasculogenic mimicry density and tumor necrosis ratio(r=-0.978,P<0.05);there is also negative correlation between the endothelial vessel density and tumor necrosis ratio(r=-0.230,P<0.05).Conclusion: The vasculogenic mimicry is one sort of special blood-providing patterns and its appearance makes the tumor adapt the micronevironment more freely.This structure usually co-exist with endothelial vessel in some tumor.The vasculogenic mimicry decreases gradually with tumor development and the density of vasculogenic mimicry between center and outside area has no significant difference.The endothelial vessel also decreases gradually with tumor development and the density of endothelial vessel between center and outside area has no significant difference.The vasculogenic mimicry is more important to the tumor blood-providing than endothelial vessel in this tumor.The CD31 plays key role in this process.

Drugs Interference in Microcirculatory Patterns of Transplant Melanoma in Embryonic Chicken Model

[Effects of Endostatin and Doxycycline on Microcirculation Patterns in Melanoma and Their Relevant Molecular Mechanisms].

An Experimental Research into Endostatin Microbubble Combined with Focused Ultrasound for Anti-Tumor Angiogenesis in Colon Cancer

[Study on the Molecular Mechanism of Endostatin and Doxycycline in Suppressing Melanoma Growth].

Inhibitory Effects of Doxycycline on the Expression and Activity of MMP-2 and MMP-9 in Mouse Transplanted Tumor Model

Dissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA

The Space-Time Change of Vasculogenic Mimicry in the Melanoma Transplant Tumour

The Influence of Different Microenvironments on Melanoma Invasiveness and Microcirculation Patterns: an Animal Experiment Study in the Mouse Model

[The Influence of Different Microenvironments on Melanoma Invasiveness and Microcirculation Patterns].

High Metastasis is Inhibited in Transgenic Melanoma Cells by Endostain Gene

Melanoma xenotransplant on the chicken chorioallantoic membrane: a complex biological model for the study of cancer cell behaviour

Zooscopy of Endostatin Gene Resistant to the Highly Metastatic Capability of Melanoma Cells

Hypoxic Microenvironment Influence on VM Formation and Tumor-Related Protein Expression in Melanoma

Morphologic Research of Microcirculation Patterns in Human and Animal Melanoma

Influence of microenvironments on microcirculation patterns and tumor invasion-related protein expression in melanoma

Study on the Effect of Acute Inflammation in Suppressing Angiogenesis in Melanoma

[Anti-Tumor Effect Through Human Endostatin Gene Transfer in Mice Bearing B16 Melanoma].

Inhibition of Choroidal Melanoma Cell Growth by Electroporation-Mediated Transfer of Immunologic Cytokines or Anti-Angiogenesis Genes

The Effect That Angiostatin Inhibits Growth of Transplanted Tumor of Oral Squamous-Cell Carcinoma

Effects of Xiaojia Decoction on Expression of Vascular Endothelial Growth Factor in Transplantation Tumors of Breast Cancer in Nude Mice

Pilot study on the interaction between B16 melanoma cell-line and bone-marrow derived mesenchymal stem cells.